Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A plus sodium hyaluronate facial microdrop injection for facial skin photoaging
ChiCTR2400090466Phase 4Completed
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A and sodium hyaluronate in photoaging (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoints: CK five skin data, Blood superoxide dismutase and malondialdehyde levels and 1 more. Started Sep 2024; status: completed.
02
Drugs
botulinum toxin type Asodium hyaluronate
03
Conditions
photoaging
Beyond the preview
Go deeper on ChiCTR2400090466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090466.